{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3755, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a hub-and-spoke diagram to connect the company brand to three core pillars: team, portfolio, and financials.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/3", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-3", "loopMatches": [ { "to": 5, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "75b8c386-e12c-4807-b0f3-5e69211b24c3", "evidence": "The deck highlights the unmet needs and limitations of current treatments", "position": 0, "objective": "What is the cost of not investing in Erasca's pipeline?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "7c14303c-7cf7-4655-a29d-3b1346ff20bb", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Setup", "beatSlug": "setup", "evidence": "Introduction to Erasca's vision and pipeline", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "team_bio", "function": "other", "notes": "SAB stands for Scientific Advisory Board.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/4", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-4", "loopMatches": [ { "to": 5, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "75b8c386-e12c-4807-b0f3-5e69211b24c3", "evidence": "The deck highlights the unmet needs and limitations of current treatments", "position": 0, "objective": "What is the cost of not investing in Erasca's pipeline?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "7c14303c-7cf7-4655-a29d-3b1346ff20bb", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Setup", "beatSlug": "setup", "evidence": "Introduction to Erasca's vision and pipeline", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a Gantt-style chart to represent clinical trial progress.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/5", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-5", "loopMatches": [ { "to": 5, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "75b8c386-e12c-4807-b0f3-5e69211b24c3", "evidence": "The deck highlights the unmet needs and limitations of current treatments", "position": 0, "objective": "What is the cost of not investing in Erasca's pipeline?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "7c14303c-7cf7-4655-a29d-3b1346ff20bb", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Setup", "beatSlug": "setup", "evidence": "Introduction to Erasca's vision and pipeline", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "solution", "function": "present_solution", "notes": "The diagram illustrates a biological signaling pathway with specific nodes highlighted as targets for therapeutic intervention.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/6", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 6, "beatId": "6f85f610-214d-4bc5-918d-861526aae38b", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Complication", "beatSlug": "complication", "evidence": "Highlighting the limitations of current treatments and unmet needs", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a matrix structure to map clinical assets to specific indications and trial names.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/7", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 6, "beatId": "6f85f610-214d-4bc5-918d-861526aae38b", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Complication", "beatSlug": "complication", "evidence": "Highlighting the limitations of current treatments and unmet needs", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The diagram shows the MAPK pathway inhibition. The patient population data is presented as a simple table.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/8", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 6, "beatId": "6f85f610-214d-4bc5-918d-861526aae38b", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Complication", "beatSlug": "complication", "evidence": "Highlighting the limitations of current treatments and unmet needs", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "product_demo", "function": "present_solution", "notes": "The slide uses a KINOMEscan visualization to show selectivity.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/9", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 6, "beatId": "6f85f610-214d-4bc5-918d-861526aae38b", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Complication", "beatSlug": "complication", "evidence": "Highlighting the limitations of current treatments and unmet needs", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "solution", "function": "present_solution", "notes": "The chart is a classic waterfall plot used in oncology to show best response per patient/model.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/10", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 6, "beatId": "6f85f610-214d-4bc5-918d-861526aae38b", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Complication", "beatSlug": "complication", "evidence": "Highlighting the limitations of current treatments and unmet needs", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "traction", "function": "show_traction", "notes": "The slide combines a biological pathway diagram with a clinical trial summary table to demonstrate clinical validation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/11", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-11", "loopMatches": [ { "to": 20, "from": 11, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "358fb471-d96f-4378-96a1-118dca13bdc4", "evidence": "The deck presents data supporting the potential of naporafenib and ERAS-007", "position": 1, "objective": "What are the potential benefits of investing in Erasca's pipeline?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 20, "from": 11, "beatId": "a76347f3-7542-420a-90ec-25e0eba8ea42", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Presenting data supporting the potential of naporafenib and ERAS-007", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a side-by-side comparison of two market segments, each with a big number metric and supporting clinical/regulatory context.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/12", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-12", "loopMatches": [ { "to": 20, "from": 11, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "358fb471-d96f-4378-96a1-118dca13bdc4", "evidence": "The deck presents data supporting the potential of naporafenib and ERAS-007", "position": 1, "objective": "What are the potential benefits of investing in Erasca's pipeline?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 20, "from": 11, "beatId": "a76347f3-7542-420a-90ec-25e0eba8ea42", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Presenting data supporting the potential of naporafenib and ERAS-007", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "market_sizing", "function": "size_opportunity", "notes": "Includes a biological diagram illustrating the RAS protein state transition and mutation impact.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/13", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-13", "loopMatches": [ { "to": 20, "from": 11, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "358fb471-d96f-4378-96a1-118dca13bdc4", "evidence": "The deck presents data supporting the potential of naporafenib and ERAS-007", "position": 1, "objective": "What are the potential benefits of investing in Erasca's pipeline?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 20, "from": 11, "beatId": "a76347f3-7542-420a-90ec-25e0eba8ea42", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Presenting data supporting the potential of naporafenib and ERAS-007", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "traction", "function": "analyze_data", "notes": "The chart shows lower IC50 values for the Q61X mutation group, suggesting higher sensitivity to the drug.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/14", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-14", "loopMatches": [ { "to": 20, "from": 11, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "358fb471-d96f-4378-96a1-118dca13bdc4", "evidence": "The deck presents data supporting the potential of naporafenib and ERAS-007", "position": 1, "objective": "What are the potential benefits of investing in Erasca's pipeline?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 20, "from": 11, "beatId": "a76347f3-7542-420a-90ec-25e0eba8ea42", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Presenting data supporting the potential of naporafenib and ERAS-007", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "traction", "function": "show_traction", "notes": "Waterfall plots showing best percentage change from baseline for two distinct patient cohorts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/15", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-15", "loopMatches": [ { "to": 20, "from": 11, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "358fb471-d96f-4378-96a1-118dca13bdc4", "evidence": "The deck presents data supporting the potential of naporafenib and ERAS-007", "position": 1, "objective": "What are the potential benefits of investing in Erasca's pipeline?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 20, "from": 11, "beatId": "a76347f3-7542-420a-90ec-25e0eba8ea42", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Presenting data supporting the potential of naporafenib and ERAS-007", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "problem_statement", "function": "frame_problem", "notes": "Includes a Kaplan-Meier survival curve comparing existing standard-of-care options.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/16", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-16", "loopMatches": [ { "to": 20, "from": 11, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "358fb471-d96f-4378-96a1-118dca13bdc4", "evidence": "The deck presents data supporting the potential of naporafenib and ERAS-007", "position": 1, "objective": "What are the potential benefits of investing in Erasca's pipeline?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" }, { "to": 18, "from": 16, "name": "Voice Of Customer", "slug": "51-voice-of-customer", "bestFor": "Product strategy, customer experience, market research", "matchId": "15811b97-f573-4124-b3e9-b52968ac14b4", "evidence": "The deck presents case studies and testimonials from patients and clinicians", "position": 2, "objective": "What do patients and clinicians need from cancer treatments?", "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response", "confidence": 0.6, "description": "Let customer quotes and feedback drive the narrative and validate the insight" } ], "arcBeatMatches": [ { "to": 20, "from": 11, "beatId": "a76347f3-7542-420a-90ec-25e0eba8ea42", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Presenting data supporting the potential of naporafenib and ERAS-007", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "testimonial", "function": "illustrate_case", "notes": "The slide uses a 'before-after' visual comparison to demonstrate clinical efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/17", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-17", "loopMatches": [ { "to": 20, "from": 11, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "358fb471-d96f-4378-96a1-118dca13bdc4", "evidence": "The deck presents data supporting the potential of naporafenib and ERAS-007", "position": 1, "objective": "What are the potential benefits of investing in Erasca's pipeline?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" }, { "to": 18, "from": 16, "name": "Voice Of Customer", "slug": "51-voice-of-customer", "bestFor": "Product strategy, customer experience, market research", "matchId": "15811b97-f573-4124-b3e9-b52968ac14b4", "evidence": "The deck presents case studies and testimonials from patients and clinicians", "position": 2, "objective": "What do patients and clinicians need from cancer treatments?", "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response", "confidence": 0.6, "description": "Let customer quotes and feedback drive the narrative and validate the insight" } ], "arcBeatMatches": [ { "to": 20, "from": 11, "beatId": "a76347f3-7542-420a-90ec-25e0eba8ea42", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Presenting data supporting the potential of naporafenib and ERAS-007", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide highlights US FDA Fast Track designation and superior PFS performance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/18", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-18", "loopMatches": [ { "to": 20, "from": 11, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "358fb471-d96f-4378-96a1-118dca13bdc4", "evidence": "The deck presents data supporting the potential of naporafenib and ERAS-007", "position": 1, "objective": "What are the potential benefits of investing in Erasca's pipeline?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" }, { "to": 18, "from": 16, "name": "Voice Of Customer", "slug": "51-voice-of-customer", "bestFor": "Product strategy, customer experience, market research", "matchId": "15811b97-f573-4124-b3e9-b52968ac14b4", "evidence": "The deck presents case studies and testimonials from patients and clinicians", "position": 2, "objective": "What do patients and clinicians need from cancer treatments?", "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response", "confidence": 0.6, "description": "Let customer quotes and feedback drive the narrative and validate the insight" } ], "arcBeatMatches": [ { "to": 20, "from": 11, "beatId": "a76347f3-7542-420a-90ec-25e0eba8ea42", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Presenting data supporting the potential of naporafenib and ERAS-007", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "traction", "function": "show_traction", "notes": "The chart is a mirrored bar chart (diverging bar chart) showing AE frequency by grade.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/19", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-19", "loopMatches": [ { "to": 20, "from": 11, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "358fb471-d96f-4378-96a1-118dca13bdc4", "evidence": "The deck presents data supporting the potential of naporafenib and ERAS-007", "position": 1, "objective": "What are the potential benefits of investing in Erasca's pipeline?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 20, "from": 11, "beatId": "a76347f3-7542-420a-90ec-25e0eba8ea42", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Presenting data supporting the potential of naporafenib and ERAS-007", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a 2D grid to map dose combinations against regulatory requirements (Project Optimus).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/20", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-20", "loopMatches": [ { "to": 20, "from": 11, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "358fb471-d96f-4378-96a1-118dca13bdc4", "evidence": "The deck presents data supporting the potential of naporafenib and ERAS-007", "position": 1, "objective": "What are the potential benefits of investing in Erasca's pipeline?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 20, "from": 11, "beatId": "a76347f3-7542-420a-90ec-25e0eba8ea42", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Presenting data supporting the potential of naporafenib and ERAS-007", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide outlines two distinct clinical trial programs (SEACRAFT-1 and SEACRAFT-2) with specific stages, patient cohorts, and regulatory endpoints.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/21", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-21", "loopMatches": [], "arcBeatMatches": [ { "to": 30, "from": 21, "beatId": "3afa2661-92f3-43bb-b45e-80e199ce2c84", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": null, "evidence": "Describing the potential benefits of Erasca's pipeline", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The diagram shows the RAS/MAPK signaling pathway with ERAS-007 targeting ERK.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/22", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-22", "loopMatches": [], "arcBeatMatches": [ { "to": 30, "from": 21, "beatId": "3afa2661-92f3-43bb-b45e-80e199ce2c84", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": null, "evidence": "Describing the potential benefits of Erasca's pipeline", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "solution", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/23", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-23", "loopMatches": [], "arcBeatMatches": [ { "to": 30, "from": 21, "beatId": "3afa2661-92f3-43bb-b45e-80e199ce2c84", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": null, "evidence": "Describing the potential benefits of Erasca's pipeline", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "problem_statement", "function": "frame_problem", "notes": "The chart is a Kaplan-Meier survival curve comparing a control arm to an experimental arm (EC).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/24", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 30, "from": 21, "beatId": "3afa2661-92f3-43bb-b45e-80e199ce2c84", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": null, "evidence": "Describing the potential benefits of Erasca's pipeline", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "traction", "function": "show_traction", "notes": "Shows efficacy data for ERAS-007 in combination with Encorafenib and Cetuximab.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/25", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-25", "loopMatches": [], "arcBeatMatches": [ { "to": 30, "from": 21, "beatId": "3afa2661-92f3-43bb-b45e-80e199ce2c84", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": null, "evidence": "Describing the potential benefits of Erasca's pipeline", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "traction", "function": "show_traction", "notes": "Includes waterfall plot and swimmer plot for clinical trial results.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/26", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-26", "loopMatches": [], "arcBeatMatches": [ { "to": 30, "from": 21, "beatId": "3afa2661-92f3-43bb-b45e-80e199ce2c84", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": null, "evidence": "Describing the potential benefits of Erasca's pipeline", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "appendix_data", "function": "analyze_data", "notes": "Data cutoff 23MAR2023. TRAE = Treatment-related Adverse Event. EC = Encorafenib + Cetuximab.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/27", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-27", "loopMatches": [], "arcBeatMatches": [ { "to": 30, "from": 21, "beatId": "3afa2661-92f3-43bb-b45e-80e199ce2c84", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": null, "evidence": "Describing the potential benefits of Erasca's pipeline", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The diagram shows the RAS/MAPK/PI3K signaling pathway. ERAS-801 is shown as an EGFR inhibitor.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/28", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-28", "loopMatches": [], "arcBeatMatches": [ { "to": 30, "from": 21, "beatId": "3afa2661-92f3-43bb-b45e-80e199ce2c84", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": null, "evidence": "Describing the potential benefits of Erasca's pipeline", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a stacked bar chart to show mutation incidence and a comparison table to highlight clinical trial failures in GBM compared to other indications.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/29", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-29", "loopMatches": [], "arcBeatMatches": [ { "to": 30, "from": 21, "beatId": "3afa2661-92f3-43bb-b45e-80e199ce2c84", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": null, "evidence": "Describing the potential benefits of Erasca's pipeline", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a biological diagram to illustrate EGFR mutations in GBM.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/30", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-30", "loopMatches": [], "arcBeatMatches": [ { "to": 30, "from": 21, "beatId": "3afa2661-92f3-43bb-b45e-80e199ce2c84", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": null, "evidence": "Describing the potential benefits of Erasca's pipeline", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "solution", "function": "present_solution", "notes": "The slide uses western blot data to demonstrate potency and a table to demonstrate pharmacokinetic superiority in mouse models.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/31", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-31", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 31, "beatId": "655f0f34-999c-4f6f-9941-38fe6e021aa5", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Market Sizing", "beatSlug": null, "evidence": "Estimating the market potential of Erasca's treatments", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "product_demo", "function": "show_traction", "notes": "The chart is a Kaplan-Meier survival plot comparing three treatment groups.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/32", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-32", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 31, "beatId": "655f0f34-999c-4f6f-9941-38fe6e021aa5", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Market Sizing", "beatSlug": null, "evidence": "Estimating the market potential of Erasca's treatments", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "appendix_methodology", "function": "plan_implementation", "notes": "The diagram illustrates a standard 3+3 or similar dose escalation design leading to an MTD and subsequent safety expansion.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/33", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-33", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 31, "beatId": "655f0f34-999c-4f6f-9941-38fe6e021aa5", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Market Sizing", "beatSlug": null, "evidence": "Estimating the market potential of Erasca's treatments", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "timeline", "function": "plan_implementation", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/34", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-34", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 31, "beatId": "655f0f34-999c-4f6f-9941-38fe6e021aa5", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Market Sizing", "beatSlug": null, "evidence": "Estimating the market potential of Erasca's treatments", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "thesis_headline", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/35", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-35", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 31, "beatId": "655f0f34-999c-4f6f-9941-38fe6e021aa5", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Market Sizing", "beatSlug": null, "evidence": "Estimating the market potential of Erasca's treatments", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "closing_ask", "function": "state_next_steps", "notes": "Features the Lorenz attractor graphic, which is a signature visual for Erasca.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/36", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-36", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 31, "beatId": "655f0f34-999c-4f6f-9941-38fe6e021aa5", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Market Sizing", "beatSlug": null, "evidence": "Estimating the market potential of Erasca's treatments", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The table uses a heatmap-style color coding where red indicates red ocean opportunities and teal/green indicates blue ocean opportunities.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/37", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-37", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 31, "beatId": "655f0f34-999c-4f6f-9941-38fe6e021aa5", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Market Sizing", "beatSlug": null, "evidence": "Estimating the market potential of Erasca's treatments", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a two-column layout (Preclinical vs Clinical) to position the company's lead asset against competitors.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/38", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-38", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 31, "beatId": "655f0f34-999c-4f6f-9941-38fe6e021aa5", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Market Sizing", "beatSlug": null, "evidence": "Estimating the market potential of Erasca's treatments", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a comparative framework to contrast the 'Terminated' vs 'Clinical' status of competitors, with a callout box detailing the specific advantages of ERAS-007.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/39", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-39", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 40, "slideType": "solution", "function": "present_solution", "notes": "The slide uses western blot imagery to show protein expression levels (P-RSK, P-ERK, GAPDH) over time (0-72h) to prove the efficacy of ERAS-007.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/40", "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549", "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-40", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549", "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb", "documentTitle": "Erasca | Investor Presentation Deck | 41 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 41, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a log-scale line chart for PK profiles and a summary table for key metrics (Cmax, Cmin, T>IC90, T The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 5, "beatId": "7a7e7716-a32e-40a0-a8a7-091386d7e52f", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Slides 5-14 present key performance indicators and financial results.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9c8a-734a-b070-a97cd0a717a9", "docSlug": "7b4cfd06664ba993408ba69ee7e9bb5e", "documentTitle": "Essity | Results Presentation Deck | 30 slides", "authorId": "essity", "authorName": "Essity", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "valuation_reveal", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9c8a-734a-b070-a97cd0a717a9/6", "deckHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9", "deckAnchorHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9#slide-6", "loopMatches": [ { "to": 14, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "7bb2a53d-4e97-4997-baa1-9c5e99d644cb", "evidence": "The presentation implies that not taking action would result in missed opportunities.", "position": 0, "objective": "Highlighting the benefits of Essity's growth strategy", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 5, "beatId": "7a7e7716-a32e-40a0-a8a7-091386d7e52f", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Slides 5-14 present key performance indicators and financial results.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9c8a-734a-b070-a97cd0a717a9", "docSlug": "7b4cfd06664ba993408ba69ee7e9bb5e", "documentTitle": "Essity | Results Presentation Deck | 30 slides", "authorId": "essity", "authorName": "Essity", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a donut chart progression to illustrate strategic portfolio rebalancing.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9c8a-734a-b070-a97cd0a717a9/7", "deckHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9", "deckAnchorHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9#slide-7", "loopMatches": [ { "to": 14, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "7bb2a53d-4e97-4997-baa1-9c5e99d644cb", "evidence": "The presentation implies that not taking action would result in missed opportunities.", "position": 0, "objective": "Highlighting the benefits of Essity's growth strategy", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 5, "beatId": "7a7e7716-a32e-40a0-a8a7-091386d7e52f", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Slides 5-14 present key performance indicators and financial results.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9c8a-734a-b070-a97cd0a717a9", "docSlug": "7b4cfd06664ba993408ba69ee7e9bb5e", "documentTitle": "Essity | Results Presentation Deck | 30 slides", "authorId": "essity", "authorName": "Essity", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "other", "function": "other", "notes": "The slide uses a background image of people to convey a brand-focused message, with a white overlay containing the logos.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9c8a-734a-b070-a97cd0a717a9/8", "deckHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9", "deckAnchorHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9#slide-8", "loopMatches": [ { "to": 14, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "7bb2a53d-4e97-4997-baa1-9c5e99d644cb", "evidence": "The presentation implies that not taking action would result in missed opportunities.", "position": 0, "objective": "Highlighting the benefits of Essity's growth strategy", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 5, "beatId": "7a7e7716-a32e-40a0-a8a7-091386d7e52f", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Slides 5-14 present key performance indicators and financial results.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9c8a-734a-b070-a97cd0a717a9", "docSlug": "7b4cfd06664ba993408ba69ee7e9bb5e", "documentTitle": "Essity | Results Presentation Deck | 30 slides", "authorId": "essity", "authorName": "Essity", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "kpi_overview", "function": "summarize", "notes": "Uses a waterfall chart to explain sales growth and circular callouts for key performance indicators.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9c8a-734a-b070-a97cd0a717a9/9", "deckHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9", "deckAnchorHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9#slide-9", "loopMatches": [ { "to": 14, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "7bb2a53d-4e97-4997-baa1-9c5e99d644cb", "evidence": "The presentation implies that not taking action would result in missed opportunities.", "position": 0, "objective": "Highlighting the benefits of Essity's growth strategy", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 5, "beatId": "7a7e7716-a32e-40a0-a8a7-091386d7e52f", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Slides 5-14 present key performance indicators and financial results.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9c8a-734a-b070-a97cd0a717a9", "docSlug": "7b4cfd06664ba993408ba69ee7e9bb5e", "documentTitle": "Essity | Results Presentation Deck | 30 slides", "authorId": "essity", "authorName": "Essity", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses bar charts to visualize financial performance trends.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9c8a-734a-b070-a97cd0a717a9/10", "deckHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9", "deckAnchorHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9#slide-10", "loopMatches": [ { "to": 14, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "7bb2a53d-4e97-4997-baa1-9c5e99d644cb", "evidence": "The presentation implies that not taking action would result in missed opportunities.", "position": 0, "objective": "Highlighting the benefits of Essity's growth strategy", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 5, "beatId": "7a7e7716-a32e-40a0-a8a7-091386d7e52f", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Slides 5-14 present key performance indicators and financial results.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9c8a-734a-b070-a97cd0a717a9", "docSlug": "7b4cfd06664ba993408ba69ee7e9bb5e", "documentTitle": "Essity | Results Presentation Deck | 30 slides", "authorId": "essity", "authorName": "Essity", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses two bar charts to visualize financial performance over a decade.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9c8a-734a-b070-a97cd0a717a9/11", "deckHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9", "deckAnchorHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9#slide-11", "loopMatches": [ { "to": 14, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "7bb2a53d-4e97-4997-baa1-9c5e99d644cb", "evidence": "The presentation implies that not taking action would result in missed opportunities.", "position": 0, "objective": "Highlighting the benefits of Essity's growth strategy", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 5, "beatId": "7a7e7716-a32e-40a0-a8a7-091386d7e52f", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Slides 5-14 present key performance indicators and financial results.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9c8a-734a-b070-a97cd0a717a9", "docSlug": "7b4cfd06664ba993408ba69ee7e9bb5e", "documentTitle": "Essity | Results Presentation Deck | 30 slides", "authorId": "essity", "authorName": "Essity", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a callout circle to emphasize the current proposed dividend and an arrow overlay to visualize the growth trend.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9c8a-734a-b070-a97cd0a717a9/12", "deckHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9", "deckAnchorHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9#slide-12", "loopMatches": [ { "to": 14, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "7bb2a53d-4e97-4997-baa1-9c5e99d644cb", "evidence": "The presentation implies that not taking action would result in missed opportunities.", "position": 0, "objective": "Highlighting the benefits of Essity's growth strategy", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 5, "beatId": "7a7e7716-a32e-40a0-a8a7-091386d7e52f", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Slides 5-14 present key performance indicators and financial results.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9c8a-734a-b070-a97cd0a717a9", "docSlug": "7b4cfd06664ba993408ba69ee7e9bb5e", "documentTitle": "Essity | Results Presentation Deck | 30 slides", "authorId": "essity", "authorName": "Essity", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "kpi_overview", "function": "summarize", "notes": "The slide uses a grid of circular callouts to present financial KPIs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9c8a-734a-b070-a97cd0a717a9/13", "deckHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9", "deckAnchorHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9#slide-13", "loopMatches": [ { "to": 14, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "7bb2a53d-4e97-4997-baa1-9c5e99d644cb", "evidence": "The presentation implies that not taking action would result in missed opportunities.", "position": 0, "objective": "Highlighting the benefits of Essity's growth strategy", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 5, "beatId": "7a7e7716-a32e-40a0-a8a7-091386d7e52f", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Slides 5-14 present key performance indicators and financial results.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9c8a-734a-b070-a97cd0a717a9", "docSlug": "7b4cfd06664ba993408ba69ee7e9bb5e", "documentTitle": "Essity | Results Presentation Deck | 30 slides", "authorId": "essity", "authorName": "Essity", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "revenue_buildup", "function": "analyze_data", "notes": "The chart uses a standard waterfall bridge format to explain sales growth components.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9c8a-734a-b070-a97cd0a717a9/14", "deckHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9", "deckAnchorHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9#slide-14", "loopMatches": [ { "to": 14, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "7bb2a53d-4e97-4997-baa1-9c5e99d644cb", "evidence": "The presentation implies that not taking action would result in missed opportunities.", "position": 0, "objective": "Highlighting the benefits of Essity's growth strategy", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 5, "beatId": "7a7e7716-a32e-40a0-a8a7-091386d7e52f", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Slides 5-14 present key performance indicators and financial results.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9c8a-734a-b070-a97cd0a717a9", "docSlug": "7b4cfd06664ba993408ba69ee7e9bb5e", "documentTitle": "Essity | Results Presentation Deck | 30 slides", "authorId": "essity", "authorName": "Essity", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "before_after", "function": "analyze_data", "notes": "The chart uses a waterfall-bridge structure to explain margin variance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9c8a-734a-b070-a97cd0a717a9/15", "deckHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9", "deckAnchorHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9#slide-15", "loopMatches": [ { "to": 22, "from": 15, "name": "Pareto Focus", "slug": "50-pareto-focus", "bestFor": "Resource allocation, problem prioritization, efficiency improvements", "matchId": "9d449d6f-062b-46ec-aee5-e0510e76f50d", "evidence": "The presentation highlights the company's focus on specific areas.", "position": 1, "objective": "Focusing on key priorities and segments", "structure": "The Full Distribution -> The Vital Few (20%) -> The Trivial Many (80%) -> Focus Recommendation", "confidence": 0.6, "description": "Show that 80% of results come from 20% of causes to drive prioritization" } ], "arcBeatMatches": [ { "to": 22, "from": 15, "beatId": "2fc62a11-2c23-4615-9f7f-f533c3aaed46", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Development", "beatSlug": "development", "evidence": "Slides 15-22 discuss the development of different business segments and priorities.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9c8a-734a-b070-a97cd0a717a9", "docSlug": "7b4cfd06664ba993408ba69ee7e9bb5e", "documentTitle": "Essity | Results Presentation Deck | 30 slides", "authorId": "essity", "authorName": "Essity", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "section_divider", "function": "transition", "notes": "The slide serves as a visual transition to the Health & Medical segment of the presentation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9c8a-734a-b070-a97cd0a717a9/16", "deckHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9", "deckAnchorHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9#slide-16", "loopMatches": [ { "to": 22, "from": 15, "name": "Pareto Focus", "slug": "50-pareto-focus", "bestFor": "Resource allocation, problem prioritization, efficiency improvements", "matchId": "9d449d6f-062b-46ec-aee5-e0510e76f50d", "evidence": "The presentation highlights the company's focus on specific areas.", "position": 1, "objective": "Focusing on key priorities and segments", "structure": "The Full Distribution -> The Vital Few (20%) -> The Trivial Many (80%) -> Focus Recommendation", "confidence": 0.6, "description": "Show that 80% of results come from 20% of causes to drive prioritization" } ], "arcBeatMatches": [ { "to": 22, "from": 15, "beatId": "2fc62a11-2c23-4615-9f7f-f533c3aaed46", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Development", "beatSlug": "development", "evidence": "Slides 15-22 discuss the development of different business segments and priorities.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9c8a-734a-b070-a97cd0a717a9", "docSlug": "7b4cfd06664ba993408ba69ee7e9bb5e", "documentTitle": "Essity | Results Presentation Deck | 30 slides", "authorId": "essity", "authorName": "Essity", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The waterfall chart uses a break in the axis to represent the growth components between the two net sales bars.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9c8a-734a-b070-a97cd0a717a9/17", "deckHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9", "deckAnchorHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9#slide-17", "loopMatches": [ { "to": 22, "from": 15, "name": "Pareto Focus", "slug": "50-pareto-focus", "bestFor": "Resource allocation, problem prioritization, efficiency improvements", "matchId": "9d449d6f-062b-46ec-aee5-e0510e76f50d", "evidence": "The presentation highlights the company's focus on specific areas.", "position": 1, "objective": "Focusing on key priorities and segments", "structure": "The Full Distribution -> The Vital Few (20%) -> The Trivial Many (80%) -> Focus Recommendation", "confidence": 0.6, "description": "Show that 80% of results come from 20% of causes to drive prioritization" } ], "arcBeatMatches": [ { "to": 22, "from": 15, "beatId": "2fc62a11-2c23-4615-9f7f-f533c3aaed46", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Development", "beatSlug": "development", "evidence": "Slides 15-22 discuss the development of different business segments and priorities.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9c8a-734a-b070-a97cd0a717a9", "docSlug": "7b4cfd06664ba993408ba69ee7e9bb5e", "documentTitle": "Essity | Results Presentation Deck | 30 slides", "authorId": "essity", "authorName": "Essity", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "section_divider", "function": "transition", "notes": "The slide serves as a visual transition to the Consumer Goods section of the presentation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9c8a-734a-b070-a97cd0a717a9/18", "deckHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9", "deckAnchorHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9#slide-18", "loopMatches": [ { "to": 22, "from": 15, "name": "Pareto Focus", "slug": "50-pareto-focus", "bestFor": "Resource allocation, problem prioritization, efficiency improvements", "matchId": "9d449d6f-062b-46ec-aee5-e0510e76f50d", "evidence": "The presentation highlights the company's focus on specific areas.", "position": 1, "objective": "Focusing on key priorities and segments", "structure": "The Full Distribution -> The Vital Few (20%) -> The Trivial Many (80%) -> Focus Recommendation", "confidence": 0.6, "description": "Show that 80% of results come from 20% of causes to drive prioritization" } ], "arcBeatMatches": [ { "to": 22, "from": 15, "beatId": "2fc62a11-2c23-4615-9f7f-f533c3aaed46", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Development", "beatSlug": "development", "evidence": "Slides 15-22 discuss the development of different business segments and priorities.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9c8a-734a-b070-a97cd0a717a9", "docSlug": "7b4cfd06664ba993408ba69ee7e9bb5e", "documentTitle": "Essity | Results Presentation Deck | 30 slides", "authorId": "essity", "authorName": "Essity", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Uses a waterfall-bridge chart to explain the change in Net Sales.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9c8a-734a-b070-a97cd0a717a9/19", "deckHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9", "deckAnchorHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9#slide-19", "loopMatches": [ { "to": 22, "from": 15, "name": "Pareto Focus", "slug": "50-pareto-focus", "bestFor": "Resource allocation, problem prioritization, efficiency improvements", "matchId": "9d449d6f-062b-46ec-aee5-e0510e76f50d", "evidence": "The presentation highlights the company's focus on specific areas.", "position": 1, "objective": "Focusing on key priorities and segments", "structure": "The Full Distribution -> The Vital Few (20%) -> The Trivial Many (80%) -> Focus Recommendation", "confidence": 0.6, "description": "Show that 80% of results come from 20% of causes to drive prioritization" } ], "arcBeatMatches": [ { "to": 22, "from": 15, "beatId": "2fc62a11-2c23-4615-9f7f-f533c3aaed46", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Development", "beatSlug": "development", "evidence": "Slides 15-22 discuss the development of different business segments and priorities.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9c8a-734a-b070-a97cd0a717a9", "docSlug": "7b4cfd06664ba993408ba69ee7e9bb5e", "documentTitle": "Essity | Results Presentation Deck | 30 slides", "authorId": "essity", "authorName": "Essity", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9c8a-734a-b070-a97cd0a717a9/20", "deckHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9", "deckAnchorHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9#slide-20", "loopMatches": [ { "to": 22, "from": 15, "name": "Pareto Focus", "slug": "50-pareto-focus", "bestFor": "Resource allocation, problem prioritization, efficiency improvements", "matchId": "9d449d6f-062b-46ec-aee5-e0510e76f50d", "evidence": "The presentation highlights the company's focus on specific areas.", "position": 1, "objective": "Focusing on key priorities and segments", "structure": "The Full Distribution -> The Vital Few (20%) -> The Trivial Many (80%) -> Focus Recommendation", "confidence": 0.6, "description": "Show that 80% of results come from 20% of causes to drive prioritization" } ], "arcBeatMatches": [ { "to": 22, "from": 15, "beatId": "2fc62a11-2c23-4615-9f7f-f533c3aaed46", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Development", "beatSlug": "development", "evidence": "Slides 15-22 discuss the development of different business segments and priorities.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9c8a-734a-b070-a97cd0a717a9", "docSlug": "7b4cfd06664ba993408ba69ee7e9bb5e", "documentTitle": "Essity | Results Presentation Deck | 30 slides", "authorId": "essity", "authorName": "Essity", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a waterfall-style bridge to explain sales growth, followed by two circular callouts for profitability metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9c8a-734a-b070-a97cd0a717a9/21", "deckHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9", "deckAnchorHref": "/decks/019de076-9c8a-734a-b070-a97cd0a717a9#slide-21", "loopMatches": [ { "to": 22, "from": 15, "name": "Pareto Focus", "slug": "50-pareto-focus", "bestFor": "Resource allocation, problem prioritization, efficiency improvements", "matchId": "9d449d6f-062b-46ec-aee5-e0510e76f50d", "evidence": "The presentation highlights the company's focus on specific areas.", "position": 1, "objective": "Focusing on key priorities and segments", "structure": "The Full Distribution -> The Vital Few (20%) -> The Trivial Many (80%) -> Focus Recommendation", "confidence": 0.6, "description": "Show that 80% of results come from 20% of causes to drive prioritization" } ], "arcBeatMatches": [ { "to": 22, "from": 15, "beatId": "2fc62a11-2c23-4615-9f7f-f533c3aaed46", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Development", "beatSlug": "development", "evidence": "Slides 15-22 discuss the development of different business segments and priorities.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }